Venlafaxine‐induced ecchymoses and impaired platelet aggregation
- 28 September 2006
- journal article
- case report
- Published by Wiley in European Journal of Haematology
- Vol. 77 (6) , 533-537
Abstract
Objective: To describe a case of venlafaxine‐induced ecchymoses. Methods: A patient with a history of ecchymoses coincident with venlafaxine therapy was rechallenged with the drug. Her platelet function was assessed with aggregation and ATP release studies before the rechallenge and after she developed ecchymoses. In addition, the effect of venlafaxine on platelet aggregation and ATP release was studied in vitro by adding the drug to platelet‐rich plasma from normal donors. Results: After 4 wk of treatment with venlafaxine our patient developed extensive ecchymoses. At that time her platelet aggregation and release responses to epinephrine, ADP, collagen, and arachidonic acid were markedly suppressed. Adding venlafaxine to normal platelet‐rich plasma also dramatically reduced the aggregation and release responses to the same agonists as well as to serotonin, but the concentrations of venlafaxine required were 1000‐fold greater than those normally achieved clinically. Conclusions: Our patient demonstrated an idiosyncratic hypersensitivity to the platelet inhibitory effects of venlafaxine. Because venlafaxine is an inhibitor of serotonin uptake by platelets and neurons, this mechanism may contribute to the impact of this drug on platelet function. However, our in vitro studies suggest that this hypothesis is inadequate to explain the observations completely.Keywords
This publication has 13 references indexed in Scilit:
- Selective Serotonin Reuptake Inhibitors and Increased Bleeding Risk: Are We Missing Something?The American Journal of Medicine, 2006
- The Medical Management of DepressionNew England Journal of Medicine, 2005
- Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by AntidepressantsArchives of internal medicine (1960), 2004
- Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control studyBMJ, 1999
- Metabolic disposition of14C-venlafaxine in mouse, rat, dog, rhesus monkey and manXenobiotica, 1993
- 5HT2-receptors and serotonin release: Their role in human platelet aggregationLife Sciences, 1993
- Adverse vascular effects associated with fluoxetineAmerican Journal of Psychiatry, 1992
- Bleeding, a side effect of fluoxetineAmerican Journal of Psychiatry, 1992
- Peripheral Indices of Central Serotonin Function in HumansAnnals of the New York Academy of Sciences, 1990
- Effects of 5-Hydroxytryptamine on Platelet AggregationNature, 1968